SEEG-guided radiofrequency thermocoagulation of epileptic foci in the paediatric population: Feasibility, safety and efficacy.


Journal

Seizure
ISSN: 1532-2688
Titre abrégé: Seizure
Pays: England
ID NLM: 9306979

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 05 02 2019
revised: 28 05 2019
accepted: 02 07 2019
pubmed: 10 7 2019
medline: 25 1 2020
entrez: 10 7 2019
Statut: ppublish

Résumé

Focal epilepsy in children may be refractory to pharmacological treatment and surgical resection may be an appropriate option. When invasive electroencephalogram is required in the presurgical evaluation, depth electrodes can be used to create focal lesions in the epileptogenic zone using radiofrequency thermocoagulation (RFTC), to disrupt the epileptogenic zone. This study aimed to assess the efficacy and safety of RFTC in a paediatric population of 46 patients. The mean age of onset was 3.3 years and the mean age at SEEG was 8.2 years. MRI lesions were identified in 71.7% of the series, among them 60% of malformation of cortical development. 43.5% of the patients were seizure free at 1 month, 26.1% were responders. The mean duration of improvement was 6.8 months. 8 children were seizure free for >8 months and among them, 6 are currently seizure free for 8-24 months. 5 patients had functional deficits post-procedures, transient in 4 patients and prolonged in one of whom. 3/5 were anticipated following the results of cortical stimulation. Multivariate analysis found 3 independent criteria linked to RFTC efficiency one month after RFTC: frequency of the seizures before RFTC, age and number of contacts used. RFTC is a safe method for the paediatric population providing important predictive information for surgical resection. An improvement in seizure frequency, often transient, is seen in 2/3 of our patients. RTFC could be useful as a palliative technique for children with an epileptogenic zone overlapping with eloquent areas, with minimal risk of sequelae.

Identifiants

pubmed: 31288205
pii: S1059-1311(19)30078-0
doi: 10.1016/j.seizure.2019.07.004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

63-70

Informations de copyright

Copyright © 2019. Published by Elsevier Ltd.

Auteurs

Mathilde Chipaux (M)

Pediatric Neurosurgery, Rothschild Foundation, Paris, France. Electronic address: mchipaux@for.paris.

Delphine Taussig (D)

Pediatric Neurosurgery, Rothschild Foundation, Paris, France.

Georg Dorfmuller (G)

Pediatric Neurosurgery, Rothschild Foundation, Paris, France.

Nathalie Dorison (N)

Pediatric Neurosurgery, Rothschild Foundation, Paris, France.

Martin M Tisdall (MM)

Department of Neurosurgery, Great Ormond Street Hospital for Children NHS Trust, London, UK.

Stewart G Boyd (SG)

Great Ormond Street Hospital for Children NHS Trust, London, UK.

Rachel Thornton (R)

Great Ormond Street Hospital for Children NHS Trust, London, UK.

Christin Eltze (C)

Great Ormond Street Hospital for Children NHS Trust, London, UK.

Martine Fohlen (M)

Pediatric Neurosurgery, Rothschild Foundation, Paris, France.

Helen J Cross (HJ)

Great Ormond Street Hospital for Children NHS Trust, London, UK.

Sarah Ferrand-Sorbets (S)

Pediatric Neurosurgery, Rothschild Foundation, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH